RESUMEN
Early detection of breast cancer is essential for increasing survival rates, as it is one of the primary causes of death for women globally. Mammograms are extensively used by physicians for diagnosis, but selecting appropriate algorithms for image enhancement, segmentation, feature extraction, and classification remains a significant research challenge. This paper presents a computer-aided diagnosis (CAD)-based hybrid model combining convolutional neural networks (CNN) with a pruned ensembled extreme learning machine (HCPELM) to enhance breast cancer detection, segmentation, feature extraction, and classification. The model employs the rectified linear unit (ReLU) activation function to enhance data analytics after removing artifacts and pectoral muscles, and the HCPELM hybridized with the CNN model improves feature extraction. The hybrid elements are convolutional and fully connected layers. Convolutional layers extract spatial features like edges, textures, and more complex features in deeper layers. The fully connected layers take these features and combine them in a non-linear manner to perform the final classification. ELM performs classification and recognition tasks, aiming for state-of-the-art performance. This hybrid classifier is used for transfer learning by freezing certain layers and modifying the architecture to reduce parameters, easing cancer detection. The HCPELM classifier was trained using the MIAS database and evaluated against benchmark methods. It achieved a breast image recognition accuracy of 86%, outperforming benchmark deep learning models. HCPELM is demonstrating superior performance in early detection and diagnosis, thus aiding healthcare practitioners in breast cancer diagnosis.
RESUMEN
Cardiovascular diseases, prevalent as leading health concerns, demand early diagnosis for effective risk prevention. Despite numerous diagnostic models, challenges persist in network configuration and performance degradation, impacting model accuracy. In response, this paper introduces the Optimally Configured and Improved Long Short-Term Memory (OCI-LSTM) model as a robust solution. Leveraging the Salp Swarm Algorithm, irrelevant features are systematically eliminated, and the Genetic Algorithm is employed to optimize the LSTM's network configuration. Validation metrics, including the accuracy, sensitivity, specificity, and F1 score, affirm the model's efficacy. Comparative analysis with a Deep Neural Network and Deep Belief Network establishes the OCI-LSTM's superiority, showcasing a notable accuracy increase of 97.11%. These advancements position the OCI-LSTM as a promising model for accurate and efficient early diagnosis of cardiovascular diseases. Future research could explore real-world implementation and further refinement for seamless integration into clinical practice.
RESUMEN
Breast cancer remains a significant global public health concern, emphasizing the critical role of accurate histopathological analysis in diagnosis and treatment planning. In recent years, the advent of deep learning techniques has showcased notable potential in elevating the precision and efficiency of histopathological data analysis. The proposed work introduces a novel approach that harnesses the power of Transfer Learning to capitalize on knowledge gleaned from pre-trained models, adapting it to the nuanced landscape of breast cancer histopathology. Our proposed model, a Transfer Learning-based concatenated model, exhibits substantial performance enhancements compared to traditional methodologies. Leveraging well-established pretrained models such as VGG-16, MobileNetV2, ResNet50, and DenseNet121-each Convolutional Neural Network architecture designed for classification tasks-this study meticulously tunes hyperparameters to optimize model performance. The implementation of a concatenated classification model is systematically benchmarked against individual classifiers on histopathological data. Remarkably, our concatenated model achieves an impressive training accuracy of 98%. The outcomes of our experiments underscore the efficacy of this four-level concatenated model in advancing the accuracy of breast cancer histopathological data analysis. By synergizing the strengths of deep learning and transfer learning, our approach holds the potential to augment the diagnostic capabilities of pathologists, thereby contributing to more informed and personalized treatment planning for individuals diagnosed with breast cancer. This research heralds a promising stride toward leveraging cutting-edge technology to refine the understanding and management of breast cancer, marking a significant advancement in the intersection of artificial intelligence and healthcare.
RESUMEN
Convolutional neural networks (CNNs) have been extensively utilized in medical image processing to automatically extract meaningful features and classify various medical conditions, enabling faster and more accurate diagnoses. In this paper, LeNet, a classic CNN architecture, has been successfully applied to breast cancer data analysis. It demonstrates its ability to extract discriminative features and classify malignant and benign tumors with high accuracy, thereby supporting early detection and diagnosis of breast cancer. LeNet with corrected Rectified Linear Unit (ReLU), a modification of the traditional ReLU activation function, has been found to improve the performance of LeNet in breast cancer data analysis tasks via addressing the "dying ReLU" problem and enhancing the discriminative power of the extracted features. This has led to more accurate, reliable breast cancer detection and diagnosis and improved patient outcomes. Batch normalization improves the performance and training stability of small and shallow CNN architecture like LeNet. It helps to mitigate the effects of internal covariate shift, which refers to the change in the distribution of network activations during training. This classifier will lessen the overfitting problem and reduce the running time. The designed classifier is evaluated against the benchmarking deep learning models, proving that this has produced a higher recognition rate. The accuracy of the breast image recognition rate is 89.91%. This model will achieve better performance in segmentation, feature extraction, classification, and breast cancer tumor detection.